"Intelligent Convergence in Shangu Valley: Linking Biomedicine with Dongjiu" – 2024 Closed-Door Forum on Biopharmaceutical Industry

In recent years, under the strong leadership of the Shanghai Municipal Committee and the Shanghai Municipal People’s Government, Fengxian District has closely aligned with the “Healthy China” and “Beautiful China” strategies. Benchmarking against the highest international standards and best practices, the district has focused on pioneering sectors such as food, pharmaceuticals, and cosmetics, taking the initiative, seizing new opportunities, and strategically laying out its industrial chain. It has now become the most important source of innovation and a key hub for industrial development in Shanghai’s biopharmaceutical sector.

As a national-level development zone, the Shanghai Hangzhou Bay Economic and Technological Development Zone focuses on niche sectors of biopharmaceuticals, including gene therapies, small molecules, and peptides. It has currently gathered a cohort of chain-leading enterprises, represented by Zhaowei Biologics, Porton Pharma Solutions, and Angbo Biotechnology. In 2022, the Hangzhou Bay Development Zone was designated as the “Shanghai Gene Therapy Innovation Industry Base” by the Shanghai Municipal Commission of Economy and Informatization.

Shangu·Dongjiu·Life Messenger Industrial Base, leveraging Fengxian District’s robust foundation in the biopharmaceutical industry and capitalizing on Sequoia China’s financial strengths and Dongjiu Xinyi’s industrial park operational expertise, focuses on cutting-edge sectors such as gene therapies, large and small molecule drugs, and cellular immunotherapy. It aims to establish a biopharmaceutical industrial cluster distinguished by its specialization in gene-based medicines.

To further promote exchanges and cooperation in the biopharmaceutical industry, byGuided by Shanghai Hangzhou Bay Economic and Technological Development Zone, hosted by Shangu·Dongjiu·Life Messenger Industrial Base, and co-organized by VCBeat and VCBeat Select.The “Zhihui Shangu · Yilian Dongjiu” 2024 Biopharmaceutical Industry Closed-Door Meeting will be held in Shanghai on August 23 (Friday)., this closed-door meeting will invite outstanding domestic biopharmaceutical enterprises to discuss development and explore industry trends.

· Meeting Time:8February 23 (Friday) 14:00

· Venue:Shanghai ·Fengxian District

· Guiding Organizations:Shanghai Hangzhou Bay Economic and Technological Development Zone

· Organizer:Sugitani · Dongjiu · Life Messenger Industrial Base

· Co-organizers:VCBeat, VCBeat Select

This event adopts an invitation-only system,Attendance is strictly limited to key representatives from enterprises in the pharmaceutical sector (excluding active pharmaceutical ingredients), specifically those involved in small molecules, large-molecule biologics, cell and gene therapy, nucleic acid drugs, and medical devices, who have a preliminary interest in collaborating with the Sugitani · Dongjiu · Life Messenger Industrial Base., for more information, scan the QR code to add our assistant for consultation.